VYGR (STOCKS)
Voyager Therapeutics, Inc. Common Stock
$3.940000
+0.100000 (+2.60%)
Prev close: $3.840000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Alfred W. Sandrock
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $235.72M
- Employees
- 172
- P/E (TTM)
- -1.88
- P/B (TTM)
- 1.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.46 | $-0.52 | +0.0607 | +11.66% |
|
Sep 2025 (Q3)
|
$-0.47 | $-0.53 | +0.0608 | +11.45% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.54 | -0.0339 | -6.32% |
|
Mar 2025 (Q1)
|
$-0.53 | $-0.46 | -0.0720 | -15.72% |
Financial Statements
| Revenues | $40.37M |
| Benefits Costs and Expenses | $159.95M |
| Costs And Expenses | $159.95M |
| Nonoperating Income/Loss | $12.27M |
| Operating Expenses | $172.22M |
| Research and Development | $134.67M |
| Other Operating Expenses | $37.54M |
| Operating Income/Loss | -$131.84M |
| Income/Loss From Continuing Operations After Tax | -$119.72M |
| Income/Loss From Continuing Operations Before Tax | -$119.58M |
| Income Tax Expense/Benefit | $144.00K |
| Net Income/Loss | -$119.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$119.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$119.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.04 |
| Diluted Earnings Per Share | -$2.04 |
| Basic Average Shares | 58,691,136 |
| Diluted Average Shares | 58,691,136 |
| Assets | $252.28M |
| Current Assets | $202.69M |
| Cash | $201.70M |
| Accounts Receivable | $1.76M |
| Noncurrent Assets | $49.59M |
| Fixed Assets | $13.14M |
| Other Non-current Assets | $36.46M |
| Liabilities | $56.20M |
| Current Liabilities | $26.54M |
| Accounts Payable | $5.01M |
| Wages | $9.09M |
| Other Current Liabilities | $12.44M |
| Noncurrent Liabilities | $29.66M |
| Equity | $196.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $196.08M |
| Liabilities And Equity | $252.28M |
| Net Cash Flow From Operating Activities | -$132.47M |
| Net Cash Flow From Operating Activities, Continuing | -$132.47M |
| Net Cash Flow From Investing Activities | $125.45M |
| Net Cash Flow From Investing Activities, Continuing | $125.45M |
| Net Cash Flow From Financing Activities | $816.00K |
| Net Cash Flow From Financing Activities, Continuing | $816.00K |
| Net Cash Flow | -$6.21M |
| Net Cash Flow, Continuing | -$6.21M |
| Comprehensive Income/Loss | -$119.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$119.28M |
| Other Comprehensive Income/Loss | $439.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $439.00K |